Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies

doi:10.3390/books978-3-0365-8310-5

Download Url(s)

https://mdpi.com/books/pdfview/book/7693

Contributor(s)

Biersack, Bernhard (editor)

Language

English

Show full item record

Abstract

This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal.

URI

https://directory.doabooks.org/handle/20.500.12854/112567

Keywords

illudin M; retinoic acid; neuronal cells; brain tumors; anticancer agents; PROTAC; target protein; protein degradation; indication; cinnamic acid derivatives; antiproliferative activity; microtubule; tubulin stabilizer; pterostilbene; melanoma; anticancer activity; apoptosis; proliferation; hepatocellular carcinoma; eIF4A1; translation inhibitors; targeted therapies; heat shock proteins; Hsp70; Hsp40; anticancer; eEF1A; mechanism; macrocycle; heterocycle; gold; carbene ligands; metal-based drugs; esophageal cancer; carbonic anhydrases; colorectal cancer; consensus molecular subtypes; CMS; SLC-0111; targeted inhibition of carbonic anhydrases; chemotherapy; curcumin; difluorinated curcumin; CDF; pancreatic cancer; PDAC; 2-hydroxypropyl-β-cyclodextrin; cyclodextrin; adenosine deaminases acting on RNA (ADAR); anti-ADAR2; natural products; cancer; depression; anxiety disorders; autism spectrum disorder (ASD); molecular docking; molecular dynamics simulation; n/a